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Foreword
Polycystic ovarian disease is a worldwide disorder which is seen in all populations and ethnic groups, although its manifestations may vary according to ethnicity. Such patients may present with irregular menses, hirsuties, acne or other signs of androgen excess, or sometimes infertility. Unfortunately, this common and distressing condition is often either ignored or dismissed by many clinicians as essentially 'cosmetic' , and indeed often its manifestations may be mild and of little consequence. However, in many women it causes considerable concern and distress, and the hirsuties in particular can cause dramatic concern with regard to body image and feelings of femininity and attractiveness. Furthermore, there is now increasing evidence that there are long-term implications of polycystic ovarian disease over and beyond any short-term cosmetic concerns: the development of type 2 diabetes and the metabolic syndrome are clearly of major significance. But why is this condition so common, especially as it may compromise reproductive fitness in the reproductive years? Are there important genetic aspects, how can we best manage these patients, how is it related to the later development of the metabolic syndrome, and what are the optimal therapies currently and on the horizon? It should also be remembered that the condition is sometimes a secondary phenomenon to other disease states. These are the questions which Marija Pfeifer and her colleagues have addressed in this important volume based on a symposium held in 2012, where an international panel of experts gathered to try and make sense of the increasing data amassed over the past few years. We hope that by bringing together these contributions from such an international array of clinicians and scientists we can make such current knowledge available to all that may come across and treat this fascinating condition, and optimize the treatment for each and every patient.
Ashley B. Grossman, Oxford
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Preface
The most frequent disorder affecting women of reproductive age is polycystic ovary syndrome (PCOS). PCOS has long been a field surrounded by considerable uncertainty as regards its etiology and pathogenesis, identification of its manifestations within the various disciplines of medicine, as well concerning the decision as to optimal treatment modalities. In the early years, the understanding of this syndrome was based on recognizing its clinical appearance in the presence of ovarian morphology. However, recently substantial advances have been made in knowledge pertaining to the complex genetic, biochemical, metabolic, cardiovascular, and reproductive issues associated with PCOS, with the result that today an integrative approach is being established in the understanding and management of the syndrome. Insight into the specific endocrine and metabolic causes and consequences still remains the clinical cornerstone for full understanding of the syndrome and for further future development. Such advancement of our knowledge is absolutely essential since, in the absence of better therapeutic options to resolve its key metabolic and biochemical derangements, women with PCOS have for long been faced with the same problems and prospects as the majority of patients suffering from obesity and metabolic syndrome. Meanwhile, since the acronym PCOS still points to the ovary as the most prominent marker of the syndrome, the time may have come for general reappraisal of the syndrome -and its naming! -so as to adopt a far more global approach to its confrontation and more metabolic-oriented methods for its resolution.
This book presents a broad overview of recent developments in identifying the phenotypic expression of women with PCOS, this having been greatly clarified via recent clinical efforts to specifically define the syndrome, resulting in a completely new recognition of its phenotypic variability. The various parts of the volume are devoted to acquainting the reader with the metabolic and cardiovascular consequences of the syndrome, advances made in dealing with secondary forms of PCOS-like syndromes, as well as specific therapies of clinical symptoms and signs and the outcomes of these therapies. Additionally incorporated are a number of 'hot topics' related to genetic developments, endothelial causes leading to the unfavorable outcomes, and novelties in therapeutic approaches oriented to better resolution of metabolic and reproductive consequences.
